Analyst Activity – Leerink Swann Initiates Coverage On AxoGen (NASDAQ:AXGN) With a Outperform

ME Staff
-
0

Analyst Ratings For AxoGen (NASDAQ:AXGN)

Today, Leerink Swann initiated coverage on AxoGen (NASDAQ:AXGN) with a Outperform.

There are 6 buy ratings on the stock.

The current consensus rating on AxoGen (NASDAQ:AXGN) is Buy (Score: 3.00) with a consensus target price of $14.38 per share, a potential 4.80% downside.

Some recent analyst ratings include

  • 7/31/2017-Leerink Swann initiated coverage with a Outperform rating.
  • 6/29/2017-Cantor Fitzgerald initiated coverage with a Overweight rating.
  • 5/19/2017-Wedbush Reiterated Rating of Outperform.
  • 3/6/2017-Roth Capital initiated coverage with a Buy rating.
  • 11/22/2016-JMP Securities Reiterated Rating of Buy.
  • 11/22/2016-Lake Street Capital Upgrade from a “Hold ” rating to a ” Buy” rating.

Recent Insider Trading Activity For AxoGen (NASDAQ:AXGN)
AxoGen (NASDAQ:AXGN) has insider ownership of 9.33% and institutional ownership of 64.79%.

  • On 10/7/2016 Amy Mcbride Wendell, Director, bought 13,333 with an average share price of $7.50 per share and the total transaction amounting to $99,997.50. View SEC Filing
  • On 10/7/2016 John P Engels, VP, bought 4,000 with an average share price of $7.50 per share and the total transaction amounting to $30,000.00. View SEC Filing
  • On 10/7/2016 Karen L Zaderej, CEO, bought 10,000 with an average share price of $7.50 per share and the total transaction amounting to $75,000.00. View SEC Filing
  • On 10/7/2016 Peter J Mariani, CFO, bought 3,333 with an average share price of $7.50 per share and the total transaction amounting to $24,997.50. View SEC Filing
  • On 8/9/2016 Joseph M Mandato, Director, sold 149,618 with an average share price of $8.54 per share and the total transaction amounting to $1,277,737.72. View SEC Filing
  • On 8/8/2016 Joseph M Mandato, Director, sold 107,450 with an average share price of $8.63 per share and the total transaction amounting to $927,293.50. View SEC Filing
  • On 7/21/2016 James E Flynn, Insider, sold 102,136 with an average share price of $6.70 per share and the total transaction amounting to $684,311.20. View SEC Filing

Recent Trading Activity for AxoGen (NASDAQ:AXGN)
Shares of AxoGen closed the previous trading session at 15.10 down -0.50 -3.21% with 359,817 shares trading hands.